Board of Directors

GARDP’s Board meets at least twice a year and is GARDP’s ultimate policy and decision-making authority. The Board is composed of up to 15 members and includes leading international figures in global health.

The Board determines GARDP’s strategic goals and ensures that the management, through implementation of the organizational strategy and annual business and action plans, works diligently and efficiently to meet these goals. The Board establishes the policies and principles followed by GARDP and appoints the Chair, Vice-chair, and Treasurer of the Board as well as the Executive Director.

Procedures for the appointment of Board members are guided by GARDP’s Statutes and By-laws as approved by the Swiss Supervisory Board for Foundations.


Ramanan Laxminarayan

Center for Disease Dynamics, Economics & Policy, USA

Marie-Paule Kieny

Institut National de la Santé et de la Recherche Médicale, France

Frédéric Vallat

Ville de Genéve, Switzerland

Professor Glenda Gray portraitGlenda Gray

South African Medical Research Council, South Africa

Joanne LiuJoanne Liu

Médecins Sans Frontières

Marcel Tanner

University of Basel, Switzerland


Bernard Pécoul

Drugs for Neglected Diseases initiative, Switzerland

Soumya SwaminathanSoumya Swaminathan

World Health Organization


Manica Balasegaram picture, photo credit JCNougaret/MSFManica Balasegaram

Executive Director, GARDP, Switzerland
Ex officio


Scientific Advisory Committee

The Scientific Advisory Committee (SAC) comprises scientists with expertise in various disciplines within infectious diseases and microbiology including drug discovery and development, medicinal chemistry, antimicrobial resistance, paediatrics and neonatology, and public health. The SAC has a consultative function: its members advise GARDP’s Board of Directors in order to carry out GARDP’s scientific objectives, assess GARDP’s scientific strategy and projects, and provide guidance and medical and scientific expertise to GARDP’s programmes.

The SAC operates independently of the Board of Directors and GARDP’s Management Team. The Board of Directors approves the selection of members.


Jutta Heim

University of Basel, Switzerland

Karl-Heinz Altmann

Swiss Federal Institute of Technology, Switzerland

Rashmi H Barbhaiya

Advinus Therapeutics, India

Anthony Coates

St George’s University, UK

George L Drusano

Institute for Therapeutic Innovation, University of Florida, USA

Prabhavathi Fernandes

Formerly Cempra Pharmaceuticals, USA

Mark J Goldberger

Fomerly AbbVie, USA

Kazuki Hoshino

Vice President, Daiichi Sankyo Biotech Co., Ltd

Rudo Mathivha

Marc Mendelson

University of Cape Town, South Africa

Malcolm Page

Formerly Roche, Switzerland

David Shlaes

Formerly Case Western Reserve University, USA

Kamini Walia

Indian Council of Medical Research, India

Nicholas White

Mahidol University, Thailand


Drugs for Neglected Diseases initiative

Graeme Bilbe


Médecins Sans Frontières

Jorgen Stassijns


Wellcome Trust

Tim Jinks


World Health Organization

Nicola Magrini